Meronem

Meropenem, the active ingredient in Meronem, is a carbapenem antibiotic presented as a powder for solution for injection for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, meningitis, hospital‑acquired pneumonia, severe sepsis, complicated urinary tract infections, and skin and soft tissue infections in hospitalized patients.

GNH USA supplies Meronem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meronem is a carbapenem antibiotic used to treat serious bacterial infections.

- Complicated intra‑abdominal infections: achieves clinical cure and microbiological eradication. - Meningitis: penetrates cerebrospinal fluid to treat bacterial meningitis. - Hospital‑acquired pneumonia: effective against ventilator‑associated and other nosocomial pneumonias. - Severe sepsis: provides broad‑spectrum coverage for Gram‑negative and Gram‑positive pathogens. - Complicated urinary tract infections: resolves infections caused by resistant organisms.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Vomiting: occasional emesis after infusion. - Rash: skin erythema or pruritus. - Headache: transient headache during or after dosing. - Elevated liver enzymes: mild transaminase increase.

Serious or Rare Side Effects: - Seizures: especially in patients with CNS disorders or renal impairment. - Anaphylaxis: acute hypersensitivity requiring emergency care. - Clostridioides difficile infection: severe colitis risk. - Severe neutropenia: marked reduction in white blood cells. - Renal impairment: acute kidney injury in susceptible individuals. - Hypersensitivity reactions: including Stevens‑Johnson syndrome.

Before initiating therapy, consider the following precautions.

- Renal function: adjust dose in patients with impaired renal clearance. - Allergy: avoid in individuals with known carbapenem hypersensitivity. - Seizure risk: monitor closely in patients with a history of seizures or CNS disorders. - Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. - Concomitant nephrotoxic drugs: monitor renal parameters when combined with other nephrotoxic agents. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meronem may interact with several medicines; monitor as indicated.

Major Interactions (Avoid): - Valproic acid: may lower valproate levels, increasing seizure risk. - Probenecid: can raise meropenem concentrations, heightening toxicity. - Other β‑lactams: additive nephrotoxicity when used together.

Moderate Interactions (Monitor Closely): - Aminoglycosides: watch renal function and drug levels. - Loop diuretics: monitor electrolytes and renal status. - Warfarin: may affect INR; check coagulation parameters regularly.